Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Endocrine-Related Cancer|July 28, 2022
Androgen receptor mutations for precision medicine in prostate cancerMasaki Shiota, Shusuke Akamatsu, Shigehiro Tsukahara, et al.Urology Practice|April 27, 2023
Adverse Events of Abiraterone Acetate vs EnzalutamideLeandro Blas, Masaki Shiota, Shigehiro Tsukahara, et al.Clinical Genitourinary Cancer|October 9, 2023
Adverse Events of Cabozantinib Plus Nivolumab Versus Ipilimumab Plus NivolumabLeandro Blas, Masaki Shiota, Shigehiro Tsukahara, et al.Cancer Medicine|July 27, 2025
Nationwide Genomic Data Analysis of Japanese Prostate Cancer Patients From C-CAT DatabaseShigehiro Tsukahara, Masaki Shiota, Shohei Nagakawa, et al.Cancer Science|July 13, 2026
Proteomic Analysis Reveals AMPKα-Mediated Antiandrogen Resistance via Ferroptosis Suppression in Prostate CancerMasaki Shiota, Tokiyoshi Tanegashima, Takahiko Hajime, et al.Free Radical Biology & Medicine|May 18, 2024
Oxidative stress in peroxisomes induced by androgen receptor inhibition through peroxisome proliferator-activated receptor promotes enzalutamide resistance in prostate cancerMasaki Shiota, Miho Ushijima, Shigehiro Tsukahara, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|January 9, 2024
Clinical features and oncological outcomes of bladder cancer microsatellite instabilityShohei Nagakawa, Masaki Shiota, Dai Takamatsu, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|February 1, 2022
Validation of models predicting lymph node involvement probability in patients with prostate cancerLeandro Blas, Masaki Shiota, Shohei Nagakawa, et al.Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|July 21, 2023
NR5A2/HSD3B1 pathway promotes cellular resistance to second-generation antiandrogen darolutamideMasaki Shiota, Miho Ushijima, Shigehiro Tsukahara, et al.Asian Journal of Urology|February 1, 2023
Validation of user-friendly models predicting extracapsular extension in prostate cancer patientsLeandro Blas, Masaki Shiota, Shohei Nagakawa, et al.Pageof 2